Is There A Cure For AIDS?

May 1988
Public Health Reports;May/Jun88, Vol. 103 Issue 3, p333
Academic Journal
The article reveals that presently. there is no cure for AIDS. Medicines such as AZT have prolonged the lives of some patients with AIDS. There is no vaccine to prevent uninfected people from getting AIDS. The article reports that it may take years for an effective, safe vaccine to be found. It suggests that the most effective way to prevent AIDS is to avoid exposure to the virus.


Related Articles

  • Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern? Thorne, Claire; Newell, Marie-Louise // Drug Safety;2007, Vol. 30 Issue 3, p203 

    Antiretroviral drugs have been used routinely to reduce the risk of mother-to-child transmission of HIV infection since 1994, following the AIDS Clinical Trials Group 076 trial, which demonstrated the efficacy of zidovudine in reducing the risk of in utero and intrapartum transmission. The use...

  • Stopping AIDS: b. Treatment: The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex A Double-Blind, Placebo-Controlled Trial. Fischl, Margaret A.; Richman, Douglas D.; Greico, Michael; Gottlieb, Michael S.; Volberding, Paul A.; Leedom, John M.; Groopman, Jerome E.; Mildvan, Donna; Schooley, Robert T.; Jackson, George G.; Durack, David T.; King, Dannie; Laskin, Oscar L. // AIDS Reader (Branden Publishing);1988, p166 

    The article presents a reprint of the article "The Efficacy of Azidothymidine (AZT) in the Treatment of Patients With AIDS and AIDS-Related Complex A Double-Blind, Placebo-Controlled Trial," by Margaret A. Fischl et al, which appeared in the July 23, 1987 issue of New England Journal of...

  • Tracking the HIV Epidemic: Current Issues, Future Challenges. Fleming, Patricia L.; Wortley, Pascale M.; Karon, John M.; DeCock, Kevin M.; Janssen, Robert S. // American Journal of Public Health;Jul2000, Vol. 90 Issue 7, p1037 

    The emergence of a new infectious disease, AIDS, in the early 1980s resulted in the development of a national AIDS surveillance system. AIDS surveillance data provided an understanding of transmission risks and characterized communities affected by the epidemic. Later, these data provided the...

  • Awareness, Acceptance, and Action: An Emerging Framework for Understanding AIDS Stigmatizing Attitudes among Community Leaders in Barbados. Rutledge, Scott Edward; Abell, Neil // AIDS Patient Care & STDs;Mar2005, Vol. 19 Issue 3, p186 

    AIDS stigma must be acknowledged and reduced to advance HIV prevention and HIV/AIDS care in a variety of settings worldwide, including in the West Indies where national epidemics are thought to be growing rapidly. Regarded by international health organizations as a formidable barrier to service...

  • Mouth Bacteria Defends against AIDS.  // Access;Dec2004, Vol. 18 Issue 10, p5 

    Reports that researchers have discovered a possible way to prevent HIV-positive mothers from infecting their babies through breastfeeding. Findings of the University of Illinois at Chicago College of Dentistry; Discovery of a natural oral bacteria that can block HIV and cells it has already...

  • Poorer countries should do more to prevent spread of AIDS. Roehr, Bob // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;11/21/2009, Vol. 339 Issue 7731, p1166 

    The article reports on the key findings of a study for the AIDS 2031 Project which suggest that the current path of HIV prevention and treatment in poorer countries will result in a continued pandemic in 2031. The study also found that costs will escalate to 35 billion U.S. dollars and a million...

  • Combination Therapy for HIV Infection: Getting Closer. Fanci, Anthony S. // Annals of Internal Medicine;1/1/92, Vol. 116 Issue 1, p85 

    Editorial. Comments on issues regarding combination therapy with antiretroviral agents for HIV infection in the U.S. as of January 1992. Observations on research in combination therapy; Views on the use of zidovudine for HIV treatment; Insights on the role of surrogate markers.

  • An antiviral breakthrough. Cohan, Gary R. // Advocate;2/7/95, Issue 674, p43 

    Reports on using AZT with a new drug called 3TC as HIV treatment. Problems with the medications; Benefits and effectiveness of the drug combination.

  • Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998. Vuthipongse, P.; Bhadrakom, C.; Chaisilwattana, P.; Roongpisuthipong, A.; Chalermchokcharoenkit, A.; Chearskul, S.; Wanprapa, N.; Chokephaibulkit, K.; Tuchinda, M.; Wasi, C.; Chuachoowong, R.; Siriwasin, W.; Chinayon, P.; Asavapiriyanont, S.; Chotpitayasunondh, T.; Waranawat, N.; Sangtaweesin, V.; Horpaopan, S. // JAMA: Journal of the American Medical Association;4/8/98, Vol. 279 Issue 14, p1061 

    Examines the use of zidovudine (ZDV) to prevent perinatal infection with HIV. Testing of drug in the United States and Thailand; Effects of short-term antenatal regimen of ZDV; Methods used in research; Data collected; Estimated HIV transmission risk; Importance of study; Shorter regimen...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics